CHINA DEVELOPED mRNA VACCINE LIKELY TO START TRIALS NEXT MONTH

Highlights –

• China developed mRNA vaccine likely to start trials next month.
• The vaccine candidate ARCoV is said to be the furthest along the clinical trial process at present.
• The vaccine may get overseas approval to conduct Phase III clinical trial likely by end-April.
• ARCoV is being jointly developed by the AMS, Suzhou Abogen Biosciences, and Walvax Biotechnology.
  Click here to read more

  ---

  Tags : CHINA GOVERNMENT, CHINA COVID-19 VACCINE, CHINA mRNA TECHONOLOGY VACCINE, ARCoV, CHINA DEVELOPED COVID-19 VACCINE, CHINA ACADEMY OF MILITARY SCIENCE, SUZHUO ABOGEN BIOSCIENCES, WALVAX BIOTECHNOLOGY,

  ---

  SHARE THIS ARTICLE